| Previous Section | Index | Home Page |
31 Jan 2006 : Column 452W—continued
Brain Tumours (Treatment)
John Bercow: To ask the Secretary of State for Health (1) what representations she has received on the use of (a) temozolomide and (b) carmustine implants for the treatment of newly diagnosed high grade glioma; [42481]
(2) what discussions she has had with (a) scientists, (b) clinicians and (c) brain tumour charities on the use of (i) carmustine implants and (ii) temozolomide. [42482]
Ms Rosie Winterton: We are not aware of any formal representations on the use of temozolomide and carmustine implants for the treatment of newly diagnosed high grade glioma.
Ministers have not had any formal discussions on the use of temozolomide and carmustine implants for the treatment of newly diagnosed high grade glioma.
However, the Department has asked the National Institute for Health and Clinical Excellence (NICE) to appraise carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma.
As part of the appraisal process NICE has consulted with the manufacturers of carmustine implants and temozolomide as well as professional and patient groups.
NICE has now published preliminary recommendations on the use of carmustine implants and temozolomide in the treatment of newly diagnosed high-grade glioma. It is
31 Jan 2006 : Column 453W
important to note that these recommendations do not constitute the Institute's formal guidance on this technology and may change after consultation.
Breast Cancer
Rosie Cooper: To ask the Secretary of State for Health (1) how many women there are in West Lancashire aged 40 to 49 years with a family history of breast cancer; [45089]
(2) how many women in West Lancashire aged 40 to 49 years with a family history of breast cancer received a mammogram in 2004–05. [45093]
31 Jan 2006 : Column 454W
Mr. Byrne: The information requested is not held centrally.
Cancelled Operations (North-West)
Rosie Cooper: To ask the Secretary of State for Health how many operations were cancelled by each hospital in the (a) Southport and Ormskirk and (b) Liverpool in the last year for which figures are available; and how many of those patients were operated on within 28 days of the operation being cancelled. [43114]
Mr. Byrne: The table shows the number of last minute cancellations for non-clinical reasons and the number of which were operated on within 28 days for hospital trusts in the (a) Southport and Ormskirk area and (b) Liverpool area.
Notes:
1. Data are for the latest 12 months from October 2004 to September 2005.
2. A last minute cancellation is one that occurs on the day the patient was due to arrive, after they have arrived in hospital or on the day of their operation. For example, you are to be admitted to hospital on a Monday for an operation scheduled for the following day (Tuesday). If the hospital cancels your operation for non-clinical reasons on the Monday then this would count as a last minute cancellation. This includes patients who have not actually arrived in hospital and have been telephoned at home prior to their arrival.
3. An operation which is rescheduled to a time within 24 hours of the original scheduled operation should be recorded as a postponement and not as a cancellation. The QMCO collection does not record the number of postponements.
4. Some common non-clinical reasons for cancellations by the hospital include: ward beds unavailable; surgeon unavailable; emergency case needing theatre; theatre list over-ran; equipment failure; admin error; anaesthetist unavailable; theatre staff unavailable; and critical care bed unavailable.
Source:
Department of Health dataset, Quarterly Monitoring of Cancelled Operations (QMCO).
Cheshire and Merseyside Strategic Health Authority
Rosie Cooper: To ask the Secretary of State for Health what the anonymised annual salaries are for NHS chief executives within the Cheshire and Merseyside strategic health authority area, including the strategic health authority itself. [45094]
Mr. Byrne: This information is not held centrally but can be obtained from the annual reports of the relevant national health service organisations.
Choosing Health White Paper
Mr. Burstow: To ask the Secretary of State for Health how much her Department has allocated to implementing the Choosing Health White Paper; what sum has been earmarked from this allocation for the prevention, detection and treatment of (a) sexually transmitted diseases and (b) HIV/AIDS; and over what time scale. [43322]
Caroline Flint: Over the next three years £1 billion, in addition to planned mainstream funding, will be invested to catalyse action that supports people in taking responsibility for improving their health, through the implementation of the Choosing Health White Paper. Of this, £300 million, over three years, is for measures to improve sexual health.
Chronic Obstructive Pulmonary Disease
Mr. Burstow: To ask the Secretary of State for Health what plans she has to commission the production of a national service framework on chronic obstructive pulmonary disease. [43417]
Mr. Byrne: The Department is currently considering its response to the chief medical officer's recommendation that a national service framework be formulated for chronic obstructive pulmonary disease.
Departmental Advertising Campaigns
Anne Milton: To ask the Secretary of State for Health if she will list the public information advertising campaigns run by her Department in the past 12 months; and what her Department spent on (a) newspapers and (b) television advertising for those campaigns. [42515]
31 Jan 2006 : Column 455W
Jane Kennedy: Media spend on public information advertising for the Department for the period 1 January to 31 December 2005 was £23.06 million. The campaigns are listed in the table with a breakdown of newspaper and television advertising costs.
Departmental IT Systems
Mrs. Villiers: To ask the Secretary of State for Health how much her Department has spent on IT systems in each year since 1997; what the purpose of each system is; what the outturn against planned expenditure of each system was; and what the (a) planned and (b) actual date of completion was of each system. [41324]
Mr. Byrne: Information requested has been placed in the Library.
Diverticulitis
Keith Vaz: To ask the Secretary of State for Health (1) what treatment is available on the NHS for the elderly who suffer from non-life threatening diverticulitis; [44981]
(2) many people the NHS treated for diverticulitis in the last year for which figures are available; and what the cost was of treating those patients; [44982]
(3) what research her Department has (a) commissioned and (b) evaluated into the (i) life expectancy and (ii) quality of life of those suffering from non-life threatening diverticulitis. [44983]
Mr. Byrne: The symptoms, and the risk of complications, associated with diverticulitis can usually be controlled by good self-care aimed at reducing the incidence of constipation through a high-fibre diet with adequate fluid intake and exercise. For those where this is not possible stool bulking agents can be prescribed.
Information on the numbers treated for diverticulitis, and the associated cost to the national health service, is not collected.
We are not aware of any research on life expectancy, or the quality of life, for those living with diverticulitis undertaken by the Department.
| Next Section | Index | Home Page |